BFRI Biofrontera Inc

$BFRI I hope no one is short on the next quarterly announcement and the next three or you will be sorry. This is going to blow through the roof as we all know it is a viable company now and they have an existing network of clients to feed from and now with approvals they are gold.

$BFRI There is only 8 more business days until BFRIW is gone and they have no more artificial overhang from those warrant shares. Shorts will have no more cheap shares to weaponize and keep this stock down. The stock might not go up all the way but probably be better than this constant manipulation. Near-term is just noise. We all know Q3 is the seasonal summer slump and is the worst quarter. Nothing new. Hopefully a 10-20% beat over est is possible. If not, no biggie. March 2027 for Q4 and May for Q1 readouts are the most important anyway. Then the icing on top will be the early approval of their recently submitted Extremities and Trunk which is late July/ early August. Oh,and the cherry is the EOP 2 meeting probably early /mid Q1 for their acne line which they will probably just license off and get a partnership for. This stock will look different next year. 💎 Hands. If you can't handle the wait, hey there are other stocks to pick from and not telling what to do with your money

$BFRI Y'all humor me for a second. Okay, they have 30 consecutive business days of trading under a dollar before getting a notice. To which they have 180 days after that to get back to above a dollar. Isn't it interesting that they went under a dollar yesterday Oct 5th to which 30 business days would put them at Nov 16-18th. Their Q3 which is the worst revenue wise due to the seasonal sump of summer is Nov. 11-13th (maybe). Heck it can even fall on Nov 16th. Therefore, they could get hit with doubt bad news within weeks of each other. Then 180 days from that is Saturday, May 15, 2027. Q1 for them this year was May 14th. Coincidence i think not, something is up and they are trying to give them little to no wiggle room. The thing that will help them is for everything to go right and Q4 is amazing. I just found that to be interesting and this could be completely a nothingburger post.

$BFRI tempted to get in but im cooked with FDA approved $OTLK also, approving just make ppl lose money lol.

$BFRI how has this not moved an cancer drug FDA approval $MRNA doubled on hints of cancer drug approval

$BFRI stock is cheap untill it isn't. If I have learned one thing in my 22 years of investing: if fundamentals are in line, the big reward will come.

$BFRI on the way to a double digit stock! News flow is excellent…and be visible qoq and yoy!

$BFRI everybody who now sells for pennies is an idiot! No doubt about that. Breakeven on the horizon.

$BFRI fully dilluted market cap according to chatgpt is 30 million. Revenue runrate is @ 48 million. @ 52 million breakeven.

$BFRI the only fear is cash….nothing else about the company is bad besides the balance sheet and even that is improving…just not there quite yet. Q3 is around the corner and should give us a bounce back if guidance is good and profitability continued in 2026!

$BFRI Let it breathe toward that 0.80 zone in my honest opinion. The company is in a much better spot than it was the last time it traded in that price range, just have to let it play out. Probably another 2 quarters as much as I wanted it to rally now I understand good things take time.

$BFRI why is this dropping? with an approved drug which no other pharma has, one would think it would be going up. any thoughts?

$BFRI Some congestion in the $1 area. Per the Finviz chart the lower trend line of the upward channel broke around 1.26. The overall multi bottom support line is at about $.80. Good luck longs.

$BFRI i should’ve never bought this stock just because it pisses me off. I’ve spent hours looking into it and always come back to the same issue- confusion about current price & the sell off AFTER FDA approval. None of it makes any sense. While i can understand needing more revenue & them not having the “cleanest” financials it still makes no sense They have minimal dilution filed for, relative to their float and they have a recently fda approved product and have revenue coming in. That alone is about better in all ways than a large Majority of stocks on the market especially stocks that are 1$. Yes their free float is relatively high for a 1-2 buck stock but it’s not ridiculous and their market cap should be much higher. I truly can’t figure out what “the market” is waiting for to reprice this. Especially considering the amount of dilution scam machine tickers that post “positive trial news” and the stock runs 10X. But here we lose 30% on fda approval. Any thoughts?

$BFRI so is Monday the big day? Even tho news been out for 2 weeks? Everyone was always originally saying 9/28…

$BFRI According to GOOGLE: "The FDA approved the sNDA for Ameluz early on September 14, 2026, two weeks ahead of its original September 28, 2026 PDUFA deadline. With this milestone, Biofrontera's Ameluz officially became the first and only photodynamic therapy (PDT) drug approved by the FDA to treat a skin cancer (specifically superficial basal cell carcinoma) in the United States. The company plans to roll out the new indication commercially between late Q4 2026 and Q1 2027."

$BFRI $ThunderCoopersmith My thoughts for what they're worth. A main reason would be lack of major institutional ownership around 20%. That's great for you and I because they'll be buying our shares at a higher price when revenues come to fruition. I typically don't invest in medical equipment suppliers because their upside is limited. However, the current price is depressed for the potential. Low risk. Renaissance has begun to acquire shares. That's worth noting and I trust at some point they'll show they've acquired more. I like to watch them for that warm fuzzy feeling that maybe, just maybe they see the same value considering their history. Good luck.

$BFRI It is actually barely oversold with an RSI of 29 while 30 and below is the technical oversold level. It had been oversold in the last half of August with RSI topping out in the mid 70s. On a weekly basis the RSI is not oversold at 37.7. It again was probably 76-77 in the last 2/3s of August. The MACD is negative below the zero line on the daily and negative on the weekly but above the zero line. This very clearly ran hard from an interim low of .73 all the way up to 1.66 essentially into news and it’s now sold off. If this $.80 area doesn’t hold the last 3 lows or interim lows we’re $.73 in May, $.65 in Feb and $.555 in December of 2025. Good luck longs. 😀👍✌️🙏

$BFRI You all seem to be confused. I’ve been through this before. FDA approval, a short runup, then a 30% drop within a week. Just sayin. Wasn’t so bad with RNXT, but I got sick of waiting for MDAI to recover and sold at a massive loss to invest in something that would move. Look at it from the companies side.. They want to get paid to buy assets for company valuations..

$BFRI they had the new submission yesterday. What’s the approximate time when we hear from FDA, around Two months? just wondering when we get approval so it could drop down to $.50.